Participant flow

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy · Source last updated 2025-10-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   All patients in this single-arm study will be exposed to the experimental chemotherapy dose-adjustment algorithm. Algorithm for cytopenia-related delay and dose-reduction of mFOLFOX chemotherapy: Chemotherapy dose-adjustment algorithm for FOLFOX chemotherapy

   id

   FG000

   title

   Study Arm

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Physician Decision

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         52

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         48

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         4

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Participants were recruited at the Dartmouth Cancer Center from the Lebanon, NH, St. Johnsbury, VT, and Nashua, NH, clinic sites between September 14, 2020 and December 14, 2022.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice